These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36592415)

  • 1. MYB/MYBL1::QKI fusion-positive diffuse glioma.
    Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
    Wefers AK; Stichel D; Schrimpf D; Coras R; Pages M; Tauziède-Espariat A; Varlet P; Schwarz D; Söylemezoglu F; Pohl U; Pimentel J; Meyer J; Hewer E; Japp A; Joshi A; Reuss DE; Reinhardt A; Sievers P; Casalini MB; Ebrahimi A; Huang K; Koelsche C; Low HL; Rebelo O; Marnoto D; Becker AJ; Staszewski O; Mittelbronn M; Hasselblatt M; Schittenhelm J; Cheesman E; de Oliveira RS; Queiroz RGP; Valera ET; Hans VH; Korshunov A; Olar A; Ligon KL; Pfister SM; Jaunmuktane Z; Brandner S; Tatevossian RG; Ellison DW; Jacques TS; Honavar M; Aronica E; Thom M; Sahm F; von Deimling A; Jones DTW; Blumcke I; Capper D
    Acta Neuropathol; 2020 Jan; 139(1):193-209. PubMed ID: 31563982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low grade glioma with MYBL1 alteration: Case report of an uncommon pediatric neoplasm].
    Appay R; Tauziède-Espariat A; Silva K; Fritih R; Scavarda D; Delteil C; Varlet P; Figarella-Branger D
    Ann Pathol; 2021 Feb; 41(1):129-133. PubMed ID: 32732147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
    Moreira DC; Qaddoumi I; Spiller S; Bouldin TW; Davidson A; Saba-Silva N; Sullivan DV; Tanaka R; Wagner AS; Wood M; Klimo P; Job G; Devidas M; Li X; Gajjar A; Robinson GW; Chiang J
    Neuro Oncol; 2024 Jul; 26(7):1327-1334. PubMed ID: 38466086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2-FLAIR Mismatch: An Imaging Biomarker for Children's
    van Maren EA; Dankbaar JW; Wesseling P; Plasschaert S; Muhlebner A; Hoving EW; Robe PA; Snijders TJ; Hoogendijk R; Kranendonk MEG; Lequin MH
    AJNR Am J Neuroradiol; 2024 Jun; 45(6):747-752. PubMed ID: 38724203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
    Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric-type diffuse low-grade glioma with
    Kalelioglu T; Rama B; Cho BB; Lopes BM; Patel SH
    Neuroradiol J; 2023 Apr; 36(2):232-235. PubMed ID: 36074655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.
    Bandopadhayay P; Ramkissoon LA; Jain P; Bergthold G; Wala J; Zeid R; Schumacher SE; Urbanski L; O'Rourke R; Gibson WJ; Pelton K; Ramkissoon SH; Han HJ; Zhu Y; Choudhari N; Silva A; Boucher K; Henn RE; Kang YJ; Knoff D; Paolella BR; Gladden-Young A; Varlet P; Pages M; Horowitz PM; Federation A; Malkin H; Tracy AA; Seepo S; Ducar M; Van Hummelen P; Santi M; Buccoliero AM; Scagnet M; Bowers DC; Giannini C; Puget S; Hawkins C; Tabori U; Klekner A; Bognar L; Burger PC; Eberhart C; Rodriguez FJ; Hill DA; Mueller S; Haas-Kogan DA; Phillips JJ; Santagata S; Stiles CD; Bradner JE; Jabado N; Goren A; Grill J; Ligon AH; Goumnerova L; Waanders AJ; Storm PB; Kieran MW; Ligon KL; Beroukhim R; Resnick AC
    Nat Genet; 2016 Mar; 48(3):273-82. PubMed ID: 26829751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYB-QKI rearrangement in angiocentric glioma.
    Lian F; Wang LM; Qi XL; Liu LN; Wang XF; Fu J; Xiong J; Lu DH; Piao YS
    Clin Neuropathol; 2020; 39(6):263-270. PubMed ID: 32589128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
    Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
    Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
    Togashi Y; Dobashi A; Sakata S; Sato Y; Baba S; Seto A; Mitani H; Kawabata K; Takeuchi K
    Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.
    Reisz Z; Radics BL; Nemes P; Laxton R; Kaizer L; Gabor KM; Novak T; Barzo P; Al-Sarraj S; Bodi I
    Pathol Oncol Res; 2023; 29():1611231. PubMed ID: 37362245
    [No Abstract]   [Full Text] [Related]  

  • 15. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF
    Ellison DW; Hawkins C; Jones DTW; Onar-Thomas A; Pfister SM; Reifenberger G; Louis DN
    Acta Neuropathol; 2019 Apr; 137(4):683-687. PubMed ID: 30848347
    [No Abstract]   [Full Text] [Related]  

  • 16. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.
    Zhang J; Wu G; Miller CP; Tatevossian RG; Dalton JD; Tang B; Orisme W; Punchihewa C; Parker M; Qaddoumi I; Boop FA; Lu C; Kandoth C; Ding L; Lee R; Huether R; Chen X; Hedlund E; Nagahawatte P; Rusch M; Boggs K; Cheng J; Becksfort J; Ma J; Song G; Li Y; Wei L; Wang J; Shurtleff S; Easton J; Zhao D; Fulton RS; Fulton LL; Dooling DJ; Vadodaria B; Mulder HL; Tang C; Ochoa K; Mullighan CG; Gajjar A; Kriwacki R; Sheer D; Gilbertson RJ; Mardis ER; Wilson RK; Downing JR; Baker SJ; Ellison DW;
    Nat Genet; 2013 Jun; 45(6):602-12. PubMed ID: 23583981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts.
    Kyrpychova L; Vanecek T; Grossmann P; Martinek P; Steiner P; Hadravsky L; Belousova IE; Shelekhova KV; Svajdler M; Dubinsky P; Michal M; Kazakov DV
    Am J Dermatopathol; 2018 Oct; 40(10):721-726. PubMed ID: 29570128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.
    Pei J; Flieder DB; Patchefsky A; Talarchek JN; Cooper HS; Testa JR; Wei S
    Mod Pathol; 2019 Oct; 32(10):1416-1420. PubMed ID: 31028361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.